June 4, 2026

A new exploratory analysis from STAMP (EA6174) on aggressive Merkel cell cancer draws attention at ASCO 2026

May 28, 2026

The May 2026 News from ECOG-ACRIN blog is now available

May 15, 2026

The Spring 2026 advocacy blog Considering Clinical Trials is now available

April 27, 2026

The April 2026 News from ECOG-ACRIN blog is now available

March 30, 2026

The March 2026 News from ECOG-ACRIN blog is now available

March 19, 2026

Press Release: ECOG-ACRIN completes enrollment for 600-patient clinical trial focused on frontline treatment for advanced melanoma

February 27, 2026

The February 2026 News from ECOG-ACRIN blog is now available

February 13, 2026

The Winter 2026 advocacy blog Considering Clinical Trials is now available

February 3, 2026

ECOG-ACRIN legacy lung cancer studies E1594 and E5508 cited in ASCO Living Guideline 2026.3.0, therapy for stage 4 NSCLC without driver alterations

ECOG-ACRIN Cancer Research Group